Halozyme Therapeutics Inc.

Analysts Viewpoint

Halozyme Therapeutics Inc’s filing revealed that its Director Henderson Jeffrey William unloaded Company’s shares for reported $0.29 million on Mar

Stock Earnings

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Insiders Updates

Halozyme Therapeutics Inc’s recently made public that its SVP, CHIEF TECHNICAL OFFICER LaBarre Michael J. unloaded Company’s shares for reported

Stock Earnings

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Insiders Updates

Halozyme Therapeutics Inc’s filing revealed that its Director Henderson Jeffrey William unloaded Company’s shares for reported $0.28 million on Feb

Stock Earnings

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Halozyme Therapeutics

Stock Earnings

Halozyme Therapeutics Inc’s recent filing unveils that its Director Henderson Jeffrey William unloaded Company’s shares for reported $0.28 million on

Insiders Updates

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Halozyme Therapeutics

Tag: Halozyme Therapeutics Inc.